Fibroblast growth factor receptor 1 (FGFR1) gene amplification is a common gene alteration in SQCLC (encountered in 16–23% of cases) and SCLC (5.6–8%); hence, it might lead to a molecular-therapeutic option for these groups8–10. Here, FGFR1 is linked to small cell lung carcinoma.